INVO Fertility (IVF) FCF Margin Growth (3y) (2014 - 2025)
INVO Fertility (IVF) FCF Margin Growth (3y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 417.00 |
| 10 | INVO Fertility | 5.31 Mn | 4.91 Mn | 629,345.00 | 60,206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 60,206.00 |
| Jun 30, 2025 | 118,877.00 |
| Mar 31, 2025 | 106,409.00 |
| Dec 31, 2024 | 5.00 |
| Sep 30, 2024 | 68,772.00 |
| Jun 30, 2024 | 48,077.00 |
| Mar 31, 2024 | 23,383.00 |
| Dec 31, 2023 | 88,349.00 |
| Sep 30, 2023 | 14,078.00 |
| Jun 30, 2023 | -5,281.00 |
| Mar 31, 2023 | 1,188.00 |
| Dec 31, 2022 | -12,629.00 |
| Sep 30, 2022 | -51,421.00 |
| Jun 30, 2022 | -122,353.00 |
| Mar 31, 2022 | -288,618.00 |
| Dec 31, 2021 | 15,846.00 |
| Sep 30, 2021 | -64,174.00 |
| Jun 30, 2021 | -37,053.00 |
| Mar 31, 2021 | -21,765.00 |
| Dec 31, 2020 | -91,669.00 |